Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
Adriana Smith, a 31-year-old woman from Atlanta who was declared brain-dead in February, gave birth to a premature baby boy on 13 June while being kept on life support. Smith’s family confirmed that life support will be withdrawn on Tuesday, 17 June.
The child, named Chance, was delivered via emergency caesarean section and weighed around 1 pound 13 ounces at birth. He remains in the neonatal intensive care unit (NICU), with doctors expecting a stable recovery.
“He’s just fighting,” said Smith’s mother, April Newkirk, speaking to local outlet 11Alive. “We just want prayers for him. Just keep praying for him. He’s here now.”
Kept alive due to legal uncertainty
Smith was declared brain-dead on 19 February 2025, after suffering blood clots in her brain. At the time, she was eight weeks pregnant. Her family says that despite her condition, she was kept medically alive due to the interpretation of Georgia’s abortion law, known as the LIFE Act, passed in 2019.
The LIFE Act bans most abortions once a foetal heartbeat is detected, typically around six weeks, and includes limited exceptions such as cases involving medical emergencies. However, the law does not provide explicit guidance in cases involving brain death, which left Smith’s doctors uncertain about legal responsibilities.
Georgia Attorney General Chris Carr has previously stated that the law does not explicitly require hospitals to keep brain-dead pregnant women on life support, describing the legal situation as unclear. Nonetheless, the hospital involved reportedly continued life support out of caution, treating the foetus as a separate patient.
Mixed reactions from advocacy groups
The case of Adriana Smith has reignited debate in the United States over the implications of abortion laws. Anti-abortion advocates supported the hospital’s decision to maintain life support, citing the foetus’s right to life. On the other hand, reproductive rights groups have voiced concern that such legislation can remove critical medical decision-making from families.
Newkirk told 11Alive that although the family may not have chosen to end the pregnancy, they were denied the option to make that choice themselves. “I think all women should have a choice about their body,” she said. “And I think I want people to know that.”
Grieving the loss while welcoming new life
While the birth of Chance brought a glimmer of hope to the family, it has been accompanied by immense grief. Smith’s eldest child, a seven-year-old son, has been told that his mother is “asleep.”
Newkirk said the family had met with doctors to prepare for removing life support, scheduled for 2 p.m. on 17 June. “It’s kind of hard, you know,” she told 11Alive. “It’s hard to process.”
A GoFundMe campaign launched to support Smith’s family has received donations from over 3,800 people, raising more than $145,400 of its $275,000 target.
“I shouldn’t be burying my daughter,” said Newkirk. “My daughter should be burying me.”
E. coli infections rose by 26% in 2024, with over 2,500 cases reported in England
Outbreaks linked to supermarket salad leaves, contaminated beef and fresh fruit
Two deaths and over 120 hospitalisations reported in largest outbreak
Children aged 1–4 most affected, with 357 confirmed cases
Experts advise strict hygiene and food safety measures to curb spread
Cases of Shiga toxin-producing E. coli (STEC) rose by over a quarter in England last year, according to data from the UK Health Security Agency (UKHSA). A total of 2,544 cases were confirmed in 2024, up from 2,018 in 2023—a 26% increase.
The rise is partly attributed to multiple foodborne outbreaks, with supermarket salad leaves identified as the leading cause of the largest incident.
Salad-linked outbreak leads to deaths and hospitalisations
The UKHSA investigated five outbreaks of STEC last year, involving 467 confirmed cases, of which 348 were in England. Contaminated salad leaves, beef and fresh fruit were among the sources.
The largest outbreak, linked to pre-packaged salad leaves, resulted in 196 confirmed cases in England alone. Across all outbreaks, 126 individuals required hospital treatment and two people died. More than a dozen supermarket products were recalled as a precaution.
Young children and travellers among the most affected
Children aged one to four years old were the most impacted demographic, accounting for 357 cases. Experts cite lower immunity, less developed hygiene practices, and a higher likelihood of seeking medical care as contributing factors.
STEC cases linked to foreign travel also rose sharply, increasing by 60%, with 183 travel-related cases reported last year.
Health experts issue hygiene warning
Dr Gauri Godbole of the UKHSA urged the public to take preventive measures, emphasising the importance of hygiene at home and abroad.
“STEC cases rose by around a quarter in 2024. While this rise is partly due to one foodborne outbreak, we have been seeing STEC cases gradually increase since 2022, and therefore it’s important for people to take steps to prevent infection.”
She added that symptoms—including diarrhoea (sometimes bloody), stomach cramps, vomiting and dehydration—should be taken seriously.
“Wash your hands with soap and warm water, clean surfaces with bleach-based products, and avoid preparing food for others if you are symptomatic or within 48 hours of recovery.”
Parents are advised to ensure children wash their hands thoroughly, especially before eating, after playing outdoors, or after visiting petting farms.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Novo Nordisk’s Wegovy is only available via specialist NHS weight management services
Novo Nordisk loses $70bn (£52bn) in market value after major share price slump
Company cuts annual forecasts for both profit and revenue
Faces mounting competition from Eli Lilly’s Mounjaro and unauthorised compound drugs
Executive reshuffle announced as Maziar Mike Doustdar takes over as CEO
UK access to weight-loss jabs remains tightly restricted under NHS guidelines
Novo Nordisk hit by sharp fall as rivals gain ground
Novo Nordisk’s shares fell by more than 20% on Tuesday—its steepest one-day drop—wiping $70bn (£52bn) off its market capitalisation. The crash follows a revised outlook by the company, which lowered its full-year profit and sales expectations amid growing competitive pressure in the obesity drug market.
The fall pushes Novo Nordisk behind European luxury brands LVMH and Hermès in the rankings of the continent’s biggest listed companies, just weeks after reclaiming the top spot.
Profit warning and weaker sales forecast
The Danish drugmaker revised its 2025 guidance, with sales now expected to grow between 8% and 14%, down from 13% to 21%. Projected profit growth was similarly trimmed to 10%–16%, compared to the earlier range of 16%–24%.
The downgrade is attributed to several factors, including increasing demand for cheaper compound drugs—unlicensed versions of Novo’s injections—as well as competition from Eli Lilly’s GLP-1 rival, Mounjaro (Zepbound in the US).
Leadership shake-up at a critical time
Novo Nordisk announced that Maziar Mike Doustdar, currently leading international operations, will assume the role of chief executive. He will be tasked with reviving flagging demand, especially in the crucial US market.
Doustdar pledged to “increase the sense of urgency and execute differently”, aiming to “turn the picture around” in the US where market share is slipping.
Mounjaro closes in on GLP-1 dominance
GLP-1 drugs, designed to mimic hormones that regulate appetite and satiety, have become central to the growing global demand for weight-loss treatments. A recent head-to-head clinical trial, funded by Eli Lilly, showed Mounjaro delivering 20% average weight loss over 72 weeks—outperforming Novo’s Wegovy, which delivered a 14% reduction.
In May, Eli Lilly surpassed Novo Nordisk in its share of the US GLP-1 market for the first time.
Legal battles and regulatory hurdles
Novo continues to challenge unauthorised versions of its obesity jabs in court. Despite intervention by the US FDA to limit the proliferation of these compound drugs, Novo claims that mass production persists under claims of customisation and personalisation.
The company says these imitations not only pose regulatory risks but also endanger patient safety.
Limited NHS access in the UK
In the UK, Eli Lilly has gained an advantage with approval for Mounjaro to be prescribed through GP surgeries. In contrast, Novo Nordisk’s Wegovy is only available via specialist NHS weight management services.
Strict eligibility applies: patients must have a BMI over 40 and at least four related health conditions such as type 2 diabetes or sleep apnoea to qualify.
Novo’s UK chief, Sebnem Avsar Tuna, recently called on the government to broaden access, suggesting the UK could “be a role model” in tackling obesity through innovation.
Health Secretary Wes Streeting has echoed support for wider use, stating that access should be “based on need and not the ability to pay”. The government is now piloting accelerated schemes for rollout of such treatments.
Keep ReadingShow less
Making healthy choices has become increasingly difficult in the modern world
NHS surgeon Dr Karan Rajan promotes a simple three-ingredient recipe to support gut health and muscle maintenance.
The snack includes kefir yoghurt, raspberries, and chia seeds — all rich in fibre, protein, and beneficial compounds.
Dr Rajan advocates for low-cost, preventative health strategies over expensive treatments.
He stresses that fibre is often overlooked despite playing a crucial role in overall health.
His TikTok channel and book aim to make scientific health advice accessible to the public.
Simple advice, powerful results
Making healthy choices has become increasingly difficult in the modern world. From ultra-processed supermarket food to endless distractions on our devices, temptation is often just a click away. But NHS surgeon Dr Karan Rajan is working to make health advice more accessible, affordable and actionable — and his approach is finding a wide audience.
Dr Rajan, who has built a following of more than five million on TikTok, uses short-form videos to break down complex medical science into practical tips. His new book, This Book May Save Your Life, compiles what he describes as “everyday health hacks to worry less and live better”.
He believes the popularity of his content reflects a wider shift in public health thinking. “Healthcare systems in most countries have flaws,” Dr Rajan told The Independent. “It’s harder to see a healthcare professional in some cases, particularly for chronic diseases. It’s also expensive if you are going down the private route. People are realising that prevention is a cheaper, more effective longer-term solution for health than treatment when burdened with disease.”
Gut health on a budget
One of Dr Rajan’s most popular tips is a simple three-ingredient snack that supports both gut health and muscle strength. It’s cost-effective, easy to prepare, and packed with nutritional value.
To make the snack, start by microwaving the raspberries for around 30 seconds, then mash them to your desired consistency. The deep red colour signals the presence of anthocyanins — antioxidants linked to gut health. This serving alone offers roughly 5g of fibre.
Next, stir in a tablespoon of chia seeds. These are rich in both fibre and mucilage — a type of soluble fibre that feeds beneficial bacteria in the colon. The chia seeds also help thicken the mixture into a jam-like texture.
Finally, use the mixture as a topping on kefir yoghurt — a fermented dairy product that contains live cultures and offers an additional boost of probiotics and protein. An optional drizzle of honey can be added for sweetness.
Dr Rajan calls this a “power combo” — containing the three Ps of gut health: prebiotics, probiotics, and polyphenols.
Why fibre matters more than you think
While protein remains a hot topic in fitness and nutrition, Dr Rajan says fibre is the real unsung hero of good health.
“Both protein and fibre are essential,” he says. “There are plenty of foods and meal combos where you can get both, but if I had to over-index on one, it would be fibre.”
According to Dr Rajan, most adults in the UK don’t come close to the recommended 30g of dietary fibre per day, with average intakes falling below 20g. This gap, he warns, is causing many to miss out on wide-ranging health benefits.
“When it comes to human physiology, there aren’t many processes in] fibre isn’t involved in, either directly or indirectly,” he says. “Its benefits include regulating hormones, metabolism, appetite, the gut microbiome, mood, bowels and more.”
Prevention over cure
The popularity of Dr Rajan’s content may lie in its simplicity and evidence-based approach. Rather than focusing on quick fixes or restrictive diets, he promotes everyday changes that can be sustained long-term. His three-ingredient snack is a clear example of that philosophy — easy to make, nutritionally rich, and based on solid science.
As access to healthcare becomes more challenging for many, he believes prevention is not just practical but necessary.
“People want advice they can trust, but also apply,” he says. “Improving gut health and increasing fibre intake are two changes most people can make today — and they’ll feel better for it.”
Keep ReadingShow less
Samaritans currently has 22,000 listening volunteers
Samaritans plans to close at least half of its 200 branches over the next 7–10 years
Volunteers to be moved into larger regional hubs and remote call handling to be piloted
Charity says model is unsustainable; changes aim to increase volunteer flexibility and service capacity
Some volunteers express concern over the loss of smaller branch camaraderie and safe spaces
Final decision expected in September following consultation
Mental health charity plans shift to larger hubs and remote volunteering
Samaritans has announced plans to close at least 100 of its 201 branches across the UK and Ireland in the next seven to ten years, as part of a major restructuring strategy aimed at improving service delivery and reducing infrastructure costs.
The charity, which operates a 24/7 mental health helpline, says it intends to move volunteers into larger regional centres and trial a remote volunteering model. The shift is intended to provide greater flexibility, increase the number of volunteers on shift at any time, and reduce spending on building maintenance.
Concerns raised over impact on volunteers
Samaritans currently has 22,000 listening volunteers who answer calls and messages from people experiencing mental health crises. The helpline receives a call every 10 seconds, and many branches also offer in-person support.
In a video shared with volunteers, Chief Executive Julie Bentley said the charity’s limited fundraising income was increasingly being used to maintain physical branches, instead of improving services.
“Over 200 branches, varying in size from 10 to 300 volunteers, is not sustainable and hinders us providing the best possible service to people who need us,” she said. “We are engaging with our volunteers on proposed improvements that will mean we are able to answer more calls, have more volunteers on duty, and be there for more people in their darkest moments.”
The charity emphasised that it does not intend to reduce the level of service it offers. Instead, it hopes to expand its reach by making buildings and shifts more accessible and increasing volunteer numbers through flexible models.
Volunteer response: fears of “call centre-style” culture
Despite the stated goals, some long-standing volunteers have raised concerns that the changes could lead to a loss of the close-knit environment offered by smaller branches. There is particular unease about the possible shift to a “call centre-style” approach, which some feel could compromise the sense of community and safety among volunteers.
One volunteer commented:
“The current system has operated very successfully for 70 years. Now they’re thinking of dismantling it. Almost every volunteer I’ve spoken to has said if they introduce call centres, we’re out.”
Others voiced discomfort at the idea of taking sensitive calls from home, even with video support from fellow volunteers, citing the importance of having a safe, supportive physical environment.
Financial pressures and long-term planning
The proposed changes come amid financial challenges for the organisation. In its 2023–24 accounts, Samaritans reported declining income for the third consecutive year and rising operational costs.
The charity’s accounts show:
£7 million allocated to fixed assets, including branches
A property maintenance fund of £28,000
A branch support fund of £287,000
£24.6 million in charitable income
Volunteers have requested more transparency around projected cost savings from branch closures and how these funds will be reinvested.
Consultation ongoing ahead of decision
Samaritans has said that no final decisions will be made until after a consultation period concludes in September. If approved, the changes will be introduced gradually over a number of years.
The charity maintains that modernising the structure is essential for long-term sustainability and to meet the evolving needs of callers and volunteers alike.
Keep ReadingShow less
Social media has recently drawn attention to the psychological challenges
Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
Users report emotional side effects, including low motivation and feeling “stuck”
A TikTok post describing the “slow middle” of weight loss struck a chord with others
The injection can support weight loss of up to 20% over a year
Drug is now sold in UK supermarkets including Tesco and Morrisons
While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.
The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.
Now available in UK supermarket pharmacies, including Tesco and Morrisons, Mounjaro is being used more widely — but not all side effects are physical.
TikTok user describes the “slow middle” struggle
Social media has recently drawn attention to the psychological challenges that can emerge partway through treatment. TikTok creator @Swedish_Sandra described feeling emotionally flat and demotivated despite ongoing physical progress.
“It’s the period of time between the before and after photos,” she explained in a recent post. “This phase feels quiet — not the start, not the finish, just the slow middle where everything is shifting but the big change isn’t visible yet.”
Sandra encouraged others to recognise that this emotional plateau is part of the journey, calling it “the hardest bit mentally” and stressing the importance of patience and perseverance.
Users share similar experiences
Sandra’s experience resonated with many who commented on her post, saying they too had noticed a dip in motivation once the initial rapid weight loss slowed.
“I’ve been struggling for the last month wondering if all this money is worth it,” wrote one user. “My weight loss has stalled too,” added another. “It is hard to get used to when you’re used to big drops at the start.”
Several commenters offered support and perspective, with one noting:
“Even a quarter of a pound a week is still a loss. This is the phase where the weight lost is likely fat, not just water. That’s real progress.”
Sandra responded:
“The initial excitement has died down, but those ‘boring’ moments are where the steady, lasting change happens.”
A reminder that weight loss is not linear
While Mounjaro has proven effective for weight loss, the emotional and mental health aspects of the process are increasingly part of the conversation. Users are calling for greater openness around the slower, less visible phases of the journey.
The drug remains a significant tool for people managing obesity or type 2 diabetes, but the growing number of personal accounts highlight the importance of setting realistic expectations and maintaining emotional resilience throughout treatment.